Portfolio company
CardiAQ Valve Technologies (CVT)
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops transcatheter mitral valve replacement systems to treat heart disease patients through minimally invasive procedures.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
HVR Cardio
This company develops transcatheter mitral valve repair devices to treat patients with mitral regurgitation.
CoreMedic
This company develops transcatheter heart valve repair systems to treat mitral valve regurgitation for patients requiring minimally invasive cardiac interventions.
Valcare Medical
The company develops transcatheter repair and replacement technologies for heart valves to treat patients with mitral and tricuspid regurgitation.
Capstan Medical
This company develops robotic catheter platforms and implants to treat mitral and tricuspid valve disease for patients requiring heart valve repair or replacement.
CoreValve SA
This company develops trans-catheter aortic valve replacement systems for patients with severe aortic stenosis who are unsuitable for open-heart surgery.
CardioMech AS
This company develops catheter-based artificial chords to repair mitral valves for patients suffering from degenerative mitral regurgitation.
Pi-Cardia
This company develops non-implant catheter devices that modify heart valve leaflets to treat calcification and facilitate valve replacement procedures for cardiac patients.
JenaValve
This medical device company develops transcatheter heart valve replacement systems for patients suffering from symptomatic aortic regurgitation and aortic stenosis.
